Medtronic’s CoreValve Gains New Indication For High Risk Patients

Medtronic’s CoreValve system today gained a second indication from the FDA for use in patients with severe aortic stenosis who are at high risk for surgery.

Click here to read the full post on Forbes.

 

Speak Your Mind

*